4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Summit Therapeutics Inc. (SMMT) operates in the Biotechnology industry and is headquartered in Miami, United States with about 265 employees. Its market capitalization is roughly $12 billion. In the fiscal year ended 2025-12-31, SMMT reported $0M in revenue and ($1.1B) in net income.
Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $1M | — |
| Operating Income (EBIT) | ($1.1B) | ($211M) | ($89M) | ($64M) | — |
| Net Income | ($1.1B) | ($221M) | ($615M) | ($79M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($195M) | ($225M) | ($234M) | ($568M) | ($67M) | — |
| Net Income | ($189M) | ($219M) | ($232M) | ($566M) | ($63M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $751M | $436M | $203M | $664M | — |
| Total Liabilities | $92M | $47M | $125M | $538M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SMMT viewer.
About TickerBase · Data methodology & sources